Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ipca Laboratories
Pharma
FDA slams Intas, Ipca over manufacturing shortfalls at 3 plants
Late this week, the FDA slapped a trio of Form 483s on three Indian drug plants, chiding both Intas Pharmaceuticals and Ipca Laboratories.
Fraiser Kansteiner
Jul 7, 2023 10:05am
FDA orders Sun to hire a manufacturing expert for troubled plant
May 16, 2023 9:30am
Pisgah Labs to spend $55M to upgrade North Carolina facility
Jul 26, 2022 10:09am
Chloroquine, BeiGene, Merck KGaA and more—FiercePharmaAsia
Mar 27, 2020 10:56am
India challenges U.S. efforts to get potential COVID-19 drug
Mar 25, 2020 12:30pm
FDA lifts ban so Ipca so can ship unproven COVID-19 treatments
Mar 23, 2020 10:55am
